Reach Orthopaedics is developing a durable shoulder implant to treat middle-aged patients suffering from massive irreparable rotator cuff tears (MIRCT). Almost ten percent of the over-50 population has a MIRCT, but the middle-aged population is underserved by current treatment options. Designed by a team of orthopaedic surgeons and engineers with over 100-years of combined experience, Reach Orthopaedics’ novel implant restores shoulder alignment – increasing mobility and function, while reducing chronic pain. The company has received FDA Breakthrough Device designation and is looking to begin an in-human feasibility study in 2025.